{"docid":"VWS-WOO-Spc2-1135286","collapsed":true,"count":1,"unchecked":0,"snapshots_total":5,"versions":[{"archive_id":"folder_import_11269_a0d19650cc97d9e3876a4e15d317c07e","bestandsnaam":"VWS-WOO-Spc2-1135286.pdf","created_date":"2025-09-08 18:23:29","last_seen":"2025-09-08 18:23:29","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-Spc2-1135286.pdf","snippet":"To: [IECEDM@minvws.nl]\nFrom:)\nSent:Thur 7/2/2020 :56AM\nSubject: FW: Inleidende spreektekst+aangepast antwoord/factsheet GLVaccins\nSpreektekst geneesmiddelen Notaoverleg.docx\nGLvaccins aangepaste versi","digest":"4f68c8115873","dupes":5,"date_to":"2025-09-08 18:23:29","date_from":"2025-02-18 12:18:11","unchecked":false}],"raw":[{"archive_id":"folder_import_11269_a0d19650cc97d9e3876a4e15d317c07e","bestandsnaam":"VWS-WOO-Spc2-1135286.pdf","created_date":"2025-09-08 18:23:29","last_seen":"2025-09-08 18:23:29","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-Spc2-1135286.pdf","snippet":"To: [IECEDM@minvws.nl]\nFrom:)\nSent:Thur 7/2/2020 :56AM\nSubject: FW: Inleidende spreektekst+aangepast antwoord/factsheet GLVaccins\nSpreektekst geneesmiddelen Notaoverleg.docx\nGLvaccins aangepaste versi","digest":"4f68c8115873"},{"archive_id":"VWS-WOO-3220321-1012085-wjz-1f026c98-eaed-6f4c-8891-65673e0af118.zip_225","bestandsnaam":"VWS-WOO-Spc2-1135286.pdf","created_date":"2025-09-04 16:13:45","last_seen":"2025-09-04 16:13:45","from_file":"VWS-WOO-3220321-1012085-wjz-1f026c98-eaed-6f4c-8891-65673e0af118.zip","bron":"../../archieven_files/VWS-WOO-3220321-1012085-wjz-1f026c98-eaed-6f4c-8891-65673e0af118.zip","snippet":"To: [IECEDM@minvws.nl]\nFrom:)\nSent:Thur 7/2/2020 :56AM\nSubject: FW: Inleidende spreektekst+aangepast antwoord/factsheet GLVaccins\nSpreektekst geneesmiddelen Notaoverleg.docx\nGLvaccins aangepaste versi","digest":"4f68c8115873"},{"archive_id":"386123","bestandsnaam":"VWS-WOO-Spc2-1135286.pdf","created_date":"2025-03-21 07:58:28","last_seen":"2025-03-21 07:58:28","from_file":"2021.109-VWS-WOO-3220321-1012085-wjz.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2021.109-VWS-WOO-3220321-1012085-wjz.zip","snippet":"To: [IECEDM@minvws.nl]\nFrom:)\nSent:Thur 7/2/2020 :56AM\nSubject: FW: Inleidende spreektekst+aangepast antwoord/factsheet GLVaccins\nSpreektekst geneesmiddelen Notaoverleg.docx\nGLvaccins aangepaste versi","digest":"4f68c8115873"},{"archive_id":"202438","bestandsnaam":"VWS-WOO-Spc2-1135286.pdf","created_date":"2025-02-27 09:25:01","last_seen":"2025-02-27 09:25:01","from_file":"Testverzoek-VWS-WOO-3220321-1012085-wjz.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Testverzoek-VWS-WOO-3220321-1012085-wjz.zip","snippet":"To: [IECEDM@minvws.nl]\nFrom:)\nSent:Thur 7/2/2020 :56AM\nSubject: FW: Inleidende spreektekst+aangepast antwoord/factsheet GLVaccins\nSpreektekst geneesmiddelen Notaoverleg.docx\nGLvaccins aangepaste versi","digest":"4f68c8115873"},{"archive_id":"90363","bestandsnaam":"VWS-WOO-Spc2-1135286.pdf","created_date":"2025-02-18 12:18:11","last_seen":"2025-02-18 12:18:11","from_file":"VWS-WOO-3220321-1012085-wjz-b227bf8d4ac87dce1b0dc1299bb59c8292243710f75f2ba1bb4253bafb4b58fd.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\VWS-WOO-3220321-1012085-wjz-b227bf8d4ac87dce1b0dc1299bb59c8292243710f75f2ba1bb4253bafb4b58fd.zip","snippet":"To: [IECEDM@minvws.nl]\nFrom:)\nSent:Thur 7/2/2020 :56AM\nSubject: FW: Inleidende spreektekst+aangepast antwoord/factsheet GLVaccins\nSpreektekst geneesmiddelen Notaoverleg.docx\nGLvaccins aangepaste versi","digest":"4f68c8115873"}],"filename":"FW: Inleidende spreektekst + aangepast antwoord/factsheet GL Vaccins","truncated":false,"elapsed_ms":12}